Literature DB >> 1558427

Update on rifampin drug interactions. II.

S M Borcherding1, A M Baciewicz, T H Self.   

Abstract

Rifampin is a potent inducer of hepatic P450 oxidative enzymes. Clinically important drug interactions have been documented between rifampin and numerous other drugs, such as oral anticoagulants, oral contraceptives, cyclosporine, digitalis, and ketoconazole. New, potentially clinically significant rifampin drug interactions have been reported for haloperidol, several antiarrhythmics, fluconazole, diltiazem, and select benzodiazepines. Further research has been conducted for previously reported drug interactions with rifampin involving such drugs as glucocorticoids, cyclosporine, verapamil, and oral anticoagulants. Proper management of these interactions is essential to avoid therapeutic failures on initiating rifampin therapy and potential toxic reactions after discontinuing rifampin. New rifampin drug interactions will continue to be identified with future investigations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558427

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  15 in total

Review 1.  Tuberculosis: 9. Treatment.

Authors:  E Hershfield
Journal:  CMAJ       Date:  1999-08-24       Impact factor: 8.262

Review 2.  [Cytochrom-P450 mediated drug interactions caused by antibiotics].

Authors:  Christiane Thallinger; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2006-09

Review 3.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose.

Authors:  H J Feng; S L Huang; W Wang; H H Zhou
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

6.  Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs.

Authors:  G Kaltenbach; D Levêque; J D Peter; J Salmon; H Elkhaili; A Cavalier; Y Salmon; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  The metabolism of zolmitriptan: effects of an inducer and an inhibitor of cytochrome p450 on its pharmacokinetics in healthy volunteers.

Authors:  R Dixon; S French; J Kemp; M Sellers; R Yates
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 8.  Use of psychotropic drugs in patients with HIV infection.

Authors:  J L Ayuso
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

9.  P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.

Authors:  E G Schuetz; A H Schinkel; M V Relling; J D Schuetz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 10.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.